Literature DB >> 29555678

Evaluation of the Pig-Tailed Macaque (Macaca nemestrina) as a Model of Human Staphylococcus aureus Nasal Carriage.

Amy L Cole1, Yvonne Cosgrove Sweeney2, Amanda G Lasseter1, Justin M Gray1, Ashley C Beavis1, Christine F Chong1, Safarali V Hajheidari2, Alex Beyene2, Dorothy L Patton3, Alexander M Cole4.   

Abstract

Staphylococcus aureus nasal carriage is a common condition affecting both healthy and immunocompromised populations and provides a reservoir for dissemination of potentially infectious strains by casual contact. The factors regulating the onset and duration of nasal S. aureus colonization are mostly unknown, and a human-relevant animal model is needed. Here, we screened 17 pig-tailed macaques (Macaca nemestrina) for S. aureus carriage, and 14 of 17 animals tested positive in the nose at one or both screening sessions (8 weeks apart), while the other 3 animals were negative in the nose but positive in the pharynx at least once. As in humans, S. aureus colonization was densest in the nose, and treatment of the nostrils with mupirocin ointment effectively cleared the nostrils and 6 extranasal body sites. Experimental nasal S. aureus colonization was established with 104 CFU/nostril, and both autologous and nonautologous strains survived over 40 days without any apparent adverse effects. A human nasal S. aureus isolate (strain D579, sequence type 398) was carried in 4 of 6 animals for over 3 weeks. Nostrils that did eradicate experimentally applied S. aureus exhibited neutrophilic innate immunity marked by elevated nasal interleukin-1β (IL-1β), IL-8, and monocyte chemotactic protein 1 levels and a 10-fold decreased IL-1 receptor antagonist/IL-1β ratio within 7 days postinoculation, analogous to the human condition. Taken together, pig-tailed macaques represent a physiological model of human S. aureus nasal carriage that may be utilized for testing natural colonization and decolonization mechanisms as well as novel classes of anti-S. aureus therapeutics.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Staphylococcus aureus; human; mucosa; nasal carriage; nonhuman primate; pig-tailed macaque

Mesh:

Year:  2018        PMID: 29555678      PMCID: PMC5964513          DOI: 10.1128/IAI.00043-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Staphylococcus aureus screening and decolonization reduces the risk of surgical site infections in patients undergoing deep brain stimulation surgery.

Authors:  J Lefebvre; S Buffet-Bataillon; P L Henaux; L Riffaud; X Morandi; C Haegelen
Journal:  J Hosp Infect       Date:  2016-12-07       Impact factor: 3.926

2.  Are the risk factors associated with Staphylococcus aureus nasal carriage in patients the same than in healthy volunteers? Data from a cohort of patients scheduled for orthopedic material implantation.

Authors:  Elisabeth Botelho-Nevers; Philippe Berthelot; Paul Oswald Verhoeven; Florence Grattard; Celine Cazorla; Frederic Farizon; Bruno Pozzetto; Frederic Lucht
Journal:  Am J Infect Control       Date:  2014-10       Impact factor: 2.918

3.  Characterization of the retrocyclin analogue RC-101 as a preventative of Staphylococcus aureus nasal colonization.

Authors:  Ryan P Lamers; Colleen R Eade; Alan J Waring; Amy L Cole; Alexander M Cole
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

4.  Choriodecidual Group B Streptococcal Infection Induces miR-155-5p in the Fetal Lung in Macaca nemestrina.

Authors:  Ryan M McAdams; Craig J Bierle; Erica Boldenow; Samantha Weed; Jesse Tsai; Richard P Beyer; James W MacDonald; Theo K Bammler; H Denny Liggitt; Federico M Farin; Jeroen Vanderhoeven; Lakshmi Rajagopal; Kristina M Adams Waldorf
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

5.  Ten years later: still a high prevalence of MRSA in slaughter pigs despite a significant reduction in antimicrobial usage in pigs the Netherlands.

Authors:  Cindy M Dierikx; Paul D Hengeveld; Kees T Veldman; Angela de Haan; Sanne van der Voorde; Petra Y Dop; Thijs Bosch; Engeline van Duijkeren
Journal:  J Antimicrob Chemother       Date:  2016-06-03       Impact factor: 5.790

6.  Staphylococcus aureus colonization among arthroplasty patients previously treated by a decolonization protocol: a pilot study.

Authors:  Demetri M Economedes; Gregory K Deirmengian; Carl A Deirmengian
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

7.  Reclassification of Staphylococcus aureus nasal carriage types.

Authors:  Alex van Belkum; Nelianne J Verkaik; Corné P de Vogel; Hélène A Boelens; Jeroen Verveer; Jan L Nouwen; Henri A Verbrugh; Heiman F L Wertheim
Journal:  J Infect Dis       Date:  2009-06-15       Impact factor: 5.226

8.  Multi-Body-Site Microbiome and Culture Profiling of Military Trainees Suffering from Skin and Soft Tissue Infections at Fort Benning, Georgia.

Authors:  Jatinder Singh; Ryan C Johnson; Carey D Schlett; Emad M Elassal; Katrina B Crawford; Deepika Mor; Jeffrey B Lanier; Natasha N Law; William A Walters; Nimfa Teneza-Mora; Jason W Bennett; Eric R Hall; Eugene V Millar; Michael W Ellis; D Scott Merrell
Journal:  mSphere       Date:  2016-10-05       Impact factor: 4.389

9.  Localization of Staphylococcus aureus in tissue from the nasal vestibule in healthy carriers.

Authors:  Anne-Merethe Hanssen; Bert Kindlund; Niels Christian Stenklev; Anne-Sofie Furberg; Silje Fismen; Renate Slind Olsen; Mona Johannessen; Johanna Ulrica Ericson Sollid
Journal:  BMC Microbiol       Date:  2017-04-05       Impact factor: 3.605

10.  Prophages and adaptation of Staphylococcus aureus ST398 to the human clinic.

Authors:  Seydina M Diene; Anna Rita Corvaglia; Patrice François; Nathalie van der Mee-Marquet
Journal:  BMC Genomics       Date:  2017-02-06       Impact factor: 3.969

View more
  2 in total

1.  Identification of Nasal Gammaproteobacteria with Potent Activity against Staphylococcus aureus: Novel Insights into the "Noncarrier" State.

Authors:  Amy L Cole; Meera Sundar; Ana Lopez; Anna Forsman; Shibu Yooseph; Alexander M Cole
Journal:  mSphere       Date:  2021-01-06       Impact factor: 4.389

2.  Efficient infection of non-human primates with purified, cryopreserved Plasmodium knowlesi sporozoites.

Authors:  Sumana Chakravarty; Melanie J Shears; Eric R James; Urvashi Rai; Natasha Kc; Solomon Conteh; Lynn E Lambert; Patrick E Duffy; Sean C Murphy; Stephen L Hoffman
Journal:  Malar J       Date:  2022-08-27       Impact factor: 3.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.